G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2004
11/18/2004	US20040230036 cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; genetic probes for real-time detection; solid phase synthesis
11/18/2004	US20040229944 Apoptosis inducer and method of screening for a substance inhibiting acylated homoserine lactone
11/18/2004	US20040229933 Treatment of hypertension
11/18/2004	US20040229886 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
11/18/2004	US20040229883 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; therapy of metabolic, feeding, and sexual disorders including obesity
11/18/2004	US20040229845 Modified PSMA ligands and uses related thereto
11/18/2004	US20040229843 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
11/18/2004	US20040229837 Identifying a subject suffering from or being at risk for developing a neurodegenerative disease, administering to the subject an effective amount of an agonist of an A2A-adenosine receptor
11/18/2004	US20040229834 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
11/18/2004	US20040229805 Agents for producing the health-benefits of repeated exercise
11/18/2004	US20040229804 Tribonectins
11/18/2004	US20040229797 Protein that comprises an amino-acid in which one or several amino acids are deleted, substituted or added, and has effects of controlling cell migration and cell death in L-FILIP, S-FILIP, or other amino-acid sequence
11/18/2004	US20040229796 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
11/18/2004	US20040229792 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
11/18/2004	US20040229787 Transforming growth factor alpha Hlll
11/18/2004	US20040229785 Screening methods to identify treatments for autoimmune disease
11/18/2004	US20040229782 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/18/2004	US20040229781 Drug screening for agents to treat cardiovascular disorders; use of drug JTV-519, a member of the 1,4 benzothiazepine family of compounds, to repair leak in ryanodine receptor RyR2 channels
11/18/2004	US20040229383 Device for receiving a chip shaped carrier and process for assembling a plurality of such devices
11/18/2004	US20040229382 Using immobilized biopolymers to characterize nucleic acids, proteins, antibodies, viruses, plastics, aptamers and tripartate multifunctional integrated constructs; biosensor and diagnostics; food processing and quality control
11/18/2004	US20040229381 Using magnetic field gradients to transport biopolymer conjugated beads; for use in medical and genetic diagnostics; biosensors
11/18/2004	US20040229380 ErbB heterodimers as biomarkers
11/18/2004	US20040229379 Using pyruvate dehydrogenase kinase (PDHK) to identify modulators for treatment of muscle and cardiovascular disorders
11/18/2004	US20040229376 Classifying components of a substantially homogenous petroleum effluent comprising water, oil and gas; using microwave pertubations to asertain components of fluids
11/18/2004	US20040229375 Determining solubility of organic, inorganic and organo-metallic compounds related to pharmaceutical, cosmetic and agrochemical products via dispersing unknown-weight quantity of compound in solvent shake or sonicate, filter and remove non-dissolved compound, measure concentration of constituents
11/18/2004	US20040229374 System and method for determining fouling tendency by refinery feed stocks
11/18/2004	US20040229371 Method for measuring hypochlorite ion
11/18/2004	US20040229370 implantable invivo detecting device including a copolymer of: one or more indicator component monomers which individually are not sufficiently water soluble to permit their use in an aqueous environment for detecting the presence or concentration of said analyte; and one or more hydrophilic monomers
11/18/2004	US20040229369 Structural determination of intact proteins using mass spectrometry
11/18/2004	US20040229368 Processing whole blood cells and detecting intracellular components; dispense cells into reaction vessel, fix, permeabilize, stain intracellular molecules of without any intervening washing, wash cells, detect components of interest
11/18/2004	US20040229360 Transgenic ventricle tissue for use as tools in screening modulators and treatments for cardiovascular disorders; tissue targeted therapy
11/18/2004	US20040229354 Enhancement of humoral immune responses using a novel myeloid accessory cell
11/18/2004	US20040229353 Genetic engineering; incubation osteogenic cells with animal growth regulator; culturing; screening for bone cell spheroids
11/18/2004	US20040229351 Adult multipotent human progenitor tissues for use in xenogenic tissue transplantation; tissue engineering; immunotherapy
11/18/2004	US20040229347 Embossed test strip system
11/18/2004	US20040229346 Micro-particle array analysis system, micro-particle array kit, and chemical analysis method
11/18/2004	US20040229345 Biosensor for detection and measurement of modulators which activate odor sensing cells in brain; blood glucose sensor; blood pressure monitoring
11/18/2004	US20040229339 Comprises neisseria membrane protein for use as tool in generation of vaccine to prevent infection and sepsis in infants
11/18/2004	US20040229336 Using lipo-viro-particles isolated from serum of infected patient to culture, propagate and replicate hepatitis C or hepatitis G virus in culture; genetic vaccines and preventing viral diseases
11/18/2004	US20040229308 Kinesin polypeptide for use in identifying modulators for detection, treatment or prevention of cancer, nervous system and vesicular transport disorders
11/18/2004	US20040229300 Zinc-based screening test and kit for early diagnosis of prostate cancer
11/18/2004	US20040229299 Using releasable probes to detect presence of intracellular complexes associated with apoptotic pathways; diagnostic indicators of inflammatory and cell proliferative disorders
11/18/2004	US20040229298 Methods and compositions for treating cervical cancer
11/18/2004	US20040229297 Methods for cancer prognosis and diagnosis
11/18/2004	US20040229294 Using epidermal growth factor receptor complexes to diagnose and prognose health in cancer patients; drug screening
11/18/2004	US20040229293 Surface receptor complexes as biomarkers
11/18/2004	US20040229292 Enhancing memory and learning via administering neurodegenerative cells and/or animal models fibroblast growth factor-18; gene therapy and tissue targeted therapy
11/18/2004	US20040229291 Screening and therapeutic methods relating to neurogenesis
11/18/2004	US20040229289 Antigen binding peptides (abtides) from peptide libraries
11/18/2004	US20040229288 Using inhibition of von willebrand factor and glycoprotein Ib binding to identify anticoagulant agents; using increased glycokallidin concentration to diagnose cardiovascular disorders
11/18/2004	US20040229287 Using gel immobilized fusion polypeptides to screen and monitor drug-polypeptide interactions; drug screening; identifying apoptosis modulators; antitumor agents
11/18/2004	US20040229286 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
11/18/2004	US20040229285 Treating neurotransmitter dysfunction using amino acid precursors which enhance serotonin and catecholamine concentration
11/18/2004	US20040229284 Multiplex analysis of proteins
11/18/2004	US20040229283 Using mass altering label to generate a protein signature for use as diagnostic indicator in detection of cell proliferative, autoimmune, respiratory and neurodegenerative diseases; high throughput analysis of proteomes
11/18/2004	US20040229281 Methods for differentiating and monitoring parathyroid and bone status related diseases
11/18/2004	US20040229280 Comprises polypeptide, protein and/or peptide which recognize and bind to prion envelope protein for use as diagnostic tool in detecting spongiform encephalopathies; screening and removing prions from fluid products; preventing viral infection
11/18/2004	US20040229279 Diagnostic drugs for autoimmune diseases
11/18/2004	US20040229278 Protein from plasma membrane of adipocytes; controlling glucose uptake
11/18/2004	US20040229277 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229274 Synaptic activation protein compositions and method
11/18/2004	US20040229266 RNA interference mediating small RNA molecules
11/18/2004	US20040229264 Bioassay which utilizes interleukin allelic sequences and variable numbers of tandem repeats to diagnose and prognose cardiovascular disorders
11/18/2004	US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004	US20040229258 Methods of detecting neurological disorders
11/18/2004	US20040229256 Method and device for diagnostic investigation of biological samples
11/18/2004	US20040229248 cyanine, xanthene, porphyrin or coumarin dyes, used for marking probes, including nucleic acids and proteins
11/18/2004	US20040229246 Monitoring effectiveness of modulating agents on expression level, phosphorylation and cellular localization of adenosine receptors (A3AR); treating cell proliferative and inflammatory disorders
11/18/2004	US20040229245 Enhancing accuracy of biochip transcriptional patterning via imaging hybridization on DNA chips; disease diagnostics and database scanning
11/18/2004	US20040229244 Using haptoglobin phenotype to predict effectiveness of free radical scavangers on preventing vascular disorders in diabetics
11/18/2004	US20040229243 MarA family helix-turn-helix domains and their methods of use
11/18/2004	US20040229242 Methods of capturing, detecting and quantifying RNA:DNA hybrids and a modified RNase H useful therein
11/18/2004	US20040229240 Identifying modulators of receptor ligand interaction; drug screening; yeast two-hybrid assay
11/18/2004	US20040229239 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; screening tastants
11/18/2004	US20040229238 Comprises kinesin polypeptides for use as tools in identifying modulators for the treatment and prevention of cancer, neurological and vesicular transport disorders
11/18/2004	US20040229232 Compositions and methods for the diagnosis and treatment of tumor
11/18/2004	US20040229226 Analyte quantification apparatus comprised of solid support with designated test zones of immobilized capture and calibration ligands; determining cytokine, drug and nucleic acid concentration; diagnosing infection and disease
11/18/2004	US20040229222 An array of capture probes, hybridizing the target sequence to an array of capture probes to form a hybridization complex and determining the nucleotide at the detection position; amplification to prevent self-extension; sensitivity
11/18/2004	US20040229218 Using immunoglobulin which binds specifically to hepatitis envelope antigens E1 and E2 to detect viral infection
11/18/2004	US20040229217 Using glutamate transporter (BNPI)/(DNPI) proteins to identify agents which prevent and/or treat, vision, nervous system, autoimmune, inflammatory and viral disorders
11/18/2004	US20040229216 Genetically biotinylated recombinant antibody in immunofiltration assay by light addressable potentiometric sensor for identification of Venezuelan equine encephalitis virus
11/18/2004	US20040229215 Forming thin films comprised of stripped phage for the detection of poisons and biological warfare agents in air; pollution control; biosensors
11/18/2004	US20040229214 Synthetic peptides immunoreactive with Hepatitis A virus antibodies
11/18/2004	US20040229209 Model for Alzheimer's disease and other neurodegenerative diseases
11/18/2004	US20040229208 Methods for the identification of inhibitors of CAX1-like Ca+2/H+ antiporter activity in plants
11/18/2004	US20040229039 Encapsulated nanoparticles and method
11/18/2004	US20040228866 Suppressor genes
11/18/2004	US20040228865 Prevention and treatment of amyloidogenic disease
11/18/2004	US20040228861 CONTIGUOUS HEAVY AND LIGHT CHAIN SEQUENCES SPANNING COMPLEMENTARITY DETERMINING REGIONS FROM WITHIN FR1 AND/OR CDR1 THROUGH CDR3 AND/OR WITHIN FR4; cytotoxic T-lymphocyte antigen 4 (CTLA-4).
11/18/2004	US20040228858 Human monoclonal antibodies to CTLA-4
11/18/2004	US20040228851 identifying an agent that reduces the lipid binding activity of an apoE stable folding intermediate, the method comprising by contacting an apoE stable folding intermediate in a solution with a test agent and determining the effect
11/18/2004	US20040228849 IKB kinase, subunits thereof, and methods of using same
11/18/2004	US20040228846 Methods and reagents for treating glucose metabolic disorders
11/18/2004	US20040228838 Viral interleukin-6
11/18/2004	US20040228837 Methods of determining efficacy of treatments of inflammatory diseases of the bowel
11/18/2004	US20040228835 Compositions and methods for modulating vascularization
11/18/2004	US20040228834 Compositions and methods for modulating vascularization
11/18/2004	US20040228798 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection
11/18/2004	US20040228774 Microreactor, its production method, and sample screening device
11/18/2004	US20040228766 Point of care diagnostic platform

1 ... 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 ... 3937